tiprankstipranks

Intra-Cellular downgraded to Neutral from Overweight at Cantor Fitzgerald

Cantor Fitzgerald downgraded Intra-Cellular (ITCI) to Neutral from Overweight with a price target of $132, down from $135, after Johnson & Johnson said will acquire all outstanding shares of Intra-Cellular for a payment of $132 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue